OUR EXPERTs

Our ID team | Booth 1839

  • Steve Kendall
    Director, Business Development
  • Elura Fink
    Manager, Business Development
  • Peter Warn
    SVP, Infectious Diseases
  • Lloyd Payne
    EVP, Anti-infectives Operations and Head of Antibacterials
  • Laurent Fraisse
    EVP, Global Head Infectious Diseases
  • Eric Bacque
    Head of ID Platforms
  • Antonio Felici
    Director, Head of Antibacterial Discovery

 

Poster presentation

Jun. 21, 2019, 10:30 AM - 5:00 PM


In Vivo Efficacy of SPR206 in Murine Lung and Thigh Infection Models Caused by Multi-Drug Resistant Pathogens Pseudomonas aeruginosa and Acinetobacter baumannii

L. Grosser1, K. Heang1, T. Lister1, J. Teague2, P. Warn2, D. Corbett2, P. Brown3, M. Dawson3, A. Rubio1;
1Spero Therapeutics, Cambridge, MA
2Evotec, Macclesfield, United Kingdom
3Cantab Anti-infectives Ltd, Welwyn Garden City, United Kingdom
 

ASM Microbe 2019
San Francisco, CA June 20-24

PARTNER WITH us

From Target ID to IND

Evotec has more than 20 years of experience in integrated drug discovery and development in infectious diseases,  from target identification to clinical trials.

Joining forces for the next generation of antibiotics

A conversation with Laurent Fraisse
Global Head, Infectious Diseases, Evotec

Get the article here! Laurent Fraisse Evotec

Download information sheet!

Learn more about how our capabilities and platforms, global network  and strategic public-private partnerships can  accelerate the development of first-in-class treatments for hard-to-treat infectious diseases.

ID FS

For more information and to request a meeting contact us at: info@evotec.com

Get the fact sheet!